Anal intraepithelial neoplasia in a multisite study of HIV-infected and high-risk HIV-uninfected women
- 2 January 2009
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 23 (1) , 59-70
- https://doi.org/10.1097/qad.0b013e32831cc101
Abstract
To study anal intraepithelial neoplasia and its associations with anal and cervical human papillomavirus (HPV), cervical neoplasia, host immune status, and demographic and behavioral risk factors in women with and at risk for HIV infection. Point-prevalence analysis nested within a prospective study of women seen at three clinical centers of the Women's Interagency HIV Study. In 2001–2003 participants were interviewed, received a gynecological examination, anal and cervical cytology testing and, if abnormal, colposcopy-guided or anoscopy-guided biopsy of visible lesions. Exfoliated cervical and anal specimens were assessed for HPV using PCR and type-specific HPV probing. Logistic regression analyses were performed, and odds ratios (ORs) estimated risks for anal intraepithelial neoplasia. Four hundred and seventy HIV-infected and 185 HIV-uninfected women were enrolled. Low-grade anal intraepithelial neoplasia was present in 12% of HIV-infected and 5% of HIV-uninfected women. High-grade anal intraepithelial neoplasia was present in 9% of HIV-infected and 1% of HIV-uninfected women. In adjusted analyses among HIV-infected women, the risk factors for low-grade anal intraepithelial neoplasia were younger age [OR = 0.59, 95% confidence interval (CI) = 0.36–0.97], history of receptive anal intercourse (OR = 3.2, 95% CI = 1.5–6.8), anal HPV (oncogenic types only OR = 11, 95% CI = 1.2–103; oncogenic and nononcogenic types OR = 11, 95% CI = 1.3–96), and cervical HPV (oncogenic and nononcogenic types OR = 3.5, 95% CI = 1.1–11). In multivariable analyses among HIV-infected women, the only significant risk factor for high-grade anal intraepithelial neoplasia was anal HPV infection (oncogenic and nononcogenic types OR = 7.6, 95% CI = 1.5–38). Even in the era of highly active antiviral therapy, the prevalence of anal intraepithelial neoplasia was 16% in HIV-infected women. After controlling for potential confounders, several risk factors for low-grade anal intraepithelial neoplasia differed from risk factors for high-grade anal intraepithelial neoplasia.Keywords
This publication has 47 references indexed in Scilit:
- Human papillomavirus infection and tumours of the anal canal: correlation of histology, PCR detection in paraffin sections and serologyAPMIS, 2007
- The Impact of Highly Active Antiretroviral Therapy on Non-AIDS-Defining Cancers among Adults with AIDSAmerican Journal of Epidemiology, 2007
- The Women's Interagency HIV Study: an Observational Cohort Brings Clinical Sciences to the BenchClinical and Vaccine Immunology, 2005
- The value of anal cytology and human papillomavirus typing in the detection of anal intraepithelial neoplasia: a review of cases from an anoscopy clinicSexually Transmitted Infections, 2005
- Chemotherapeutic options in the management of anal cancerExpert Opinion on Pharmacotherapy, 2004
- Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical CancerNew England Journal of Medicine, 2003
- Anal intraepithelial neoplasia in HIV positive peopleSexually Transmitted Infections, 2001
- Aetiological parallel between anal cancer and cervical cancerThe Lancet, 1991
- Sexual Practices, Sexually Transmitted Diseases, and the Incidence of Anal CancerNew England Journal of Medicine, 1987
- On the existence of maximum likelihood estimates in logistic regression modelsBiometrika, 1984